Financial Consulate’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Buy
1,245
+10
+0.8% +$10.1K 0.14% 43
2025
Q4
$1.33M Buy
1,235
+6
+0.5% +$5.74K 0.18% 38
2025
Q3
$938K Buy
+1,229
New +$915K 0.13% 54
2023
Q2
Sell
-820
Closed -$282K 82
2023
Q1
$282K Buy
820
+248
+43% +$83.6K 0.1% 101
2022
Q4
$209K Buy
+572
New +$203K 0.07% 129

Other funds holding LLY

Financial Consulate's LLY Position: Q1 2026 in Review

Financial Consulate increased its Eli Lilly (LLY) stake by 0.81% in Q1 2026, buying an estimated $10.1K and bringing the position to 1,245 shares worth $1.15M. The position accounts for 0.14% of the portfolio, ranked #43.

Financial Consulate first reported a position in LLY in Q4 2022 and has held it in 5 quarters since. The position peaked at $1.33M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Financial Consulate held 1,245 shares of Eli Lilly worth $1.15M as of Q1 2026.
  • Financial Consulate bought 10 Eli Lilly shares in Q1 2026, an estimated $10.1K.
  • Eli Lilly made up 0.14% of Financial Consulate's portfolio in Q1 2026, its #43 holding.
  • Financial Consulate first reported a position in Eli Lilly in Q4 2022 and has held it in 5 quarters since.
  • Financial Consulate's Eli Lilly position peaked at $1.33M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.